Home Archive by category "Autoimmune Disorders"

Category: Autoimmune Disorders

Human Rights Commissioner troubled by end of mask mandates in healthcare settings – BC’s Office of the Human Rights Commissioner

Vancouver B.C. – On April 12, 2023, B.C.’s Human Rights Commissioner Kasari Govender released the following statement on the recent announcement that universal mask mandates in healthcare settings would be eliminated. “As mask restrictions have been lifted in B.C., I have repeatedly expressed concerns about the human rights implications of these policy decisions: that the removal of mask mandates has a disproportionate impact on marginalized people, seniors, and those who are clinically extremely vulnerable. ThisContinue…

Click here to continue!

A woman living with ME and EDS is dying in front of her husband’s eyes in an NHS hospital

A woman is fighting for her life in hospital after doctors refused to let her see specialists that may be able to help her. She lives with severe chronic illness – myalgic encephalomyelitis (ME) and Ehlers-Danlos syndromes (EDS). So, her husband has issued a desperate cry for help on her behalf. Sadly, her story will not be unfamiliar to some people. This is because NHS treatment for this disease is at best dire – andContinue…

Click here to continue!

California lawsuit accuses drugmakers, pharmacy benefit managers of insulin overcharging

(Reuters) -California is suing the United States’ leading insulin makers and pharmacy benefit managers, accusing them of using their market power to overcharge patients for the life-saving drug, the state’s attorney general announced on Thursday.The lawsuit, filed in California Superior Court in Los Angeles, targets Eli Lilly and Co, Novo Nordisk A/S and Sanofi SA, which together make more than 90% of the insulin drugs sold globally.It also names the three largest pharmacy benefit managersContinue…

Click here to continue!

Experimental Monoclonal Antibodies Show Promise Against Epstein-Barr Virus | NIH: National Institute of Allergy and Infectious Diseases

A panel of investigational monoclonal antibodies (mAbs) targeting different sites of the Epstein-Barr virus (EBV) blocked infection when tested in human cells in a laboratory setting. Moreover, one of the experimental mAbs provided nearly complete protection against EBV infection and lymphoma when tested in mice. The results appear online today in the journal Immunity. Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, in collaboration withContinue…

Click here to continue!